Molecula Maxima

Company Overview

Snapshot

Founded in January 2015, Molecula Maxima operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing a high-level bio-programming language for designing DNA sequences, a significant step in making synthetic biology more accessible.

Business overview

Molecula Maxima is developing a programming environment designed to facilitate the creation of new genetically modified organisms and drugs. The company's core technology includes a Synthetic bioprogramming language and the Cytostudio IDE, which enables engineers to design, debug, compile, and optimize chemically synthesized genes. Molecula Maxima aims to make the synthetic biology field accessible to software developers and engineers, serving the health tech and life sciences sectors, particularly in pharmaceuticals and laboratories, with a global market reach.

Strategic signal

In March 2016, Molecula Maxima was highlighted for its development of a high-level bio-programming language for designing DNA sequences. This initiative signals a strategic focus on democratizing synthetic biology, potentially accelerating innovation in genetic engineering and drug discovery by making complex biological design more accessible to a broader engineering community.

Company Intelligence Q&A

What is Molecula Maxima's primary focus?

Molecula Maxima is focused on developing a programming environment for the creation of new genetically modified organisms and drugs, aiming to make synthetic biology accessible to software developers and engineers.

What key products does Molecula Maxima offer?

Molecula Maxima offers a Synthetic bioprogramming language and the Cytostudio IDE, which are tools for designing, debugging, compiling, and optimizing chemically synthesized genes.

When was Molecula Maxima founded?

Molecula Maxima was founded in January 2015.

What was a notable development for Molecula Maxima in early 2016?

In March 2016, Molecula Maxima was featured for its high-level bio-programming language designed for DNA sequences, aimed at simplifying genetic engineering.

What industries does Molecula Maxima serve?

Molecula Maxima serves the health tech and life sciences sectors, with a particular focus on pharmaceuticals and laboratories.